Preclinical evaluation of potential therapeutic targets in dedifferentiated liposarcoma-Reference-Cited by-同舟云学术

Preclinical evaluation of potential therapeutic targets in dedifferentiated liposarcoma

Published:2016-07-09 Issue:34 Volume:7 Page:54583-54595
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Hanes Robert¹²,Grad Iwona¹,Lorenz Susanne¹²,Stratford Eva W.¹,Munthe Else¹,Reddy Chilamakuri Chandra Sekhar¹²,Meza-Zepeda Leonardo A.¹²³,Myklebost Ola¹²

Affiliation:

1. Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway

2. Norwegian Cancer Genomics Consortium, Oslo, Norway

3. Genomics Core Facility, Department of Core Facilities, Institute of Cancer Research, the Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical characterization of CPL304110 as a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3 for gastric, bladder, and squamous cell lung cancer;Frontiers in Oncology;2024-01-12

2. Genetic, Epigenetic and Transcriptome Alterations in Liposarcoma for Target Therapy Selection;Cancers;2024-01-08

3. Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression drivers;Frontiers in Oncology;2022-09-02

4. The Role of the Tumor Suppressor Gene Protein Tyrosine Phosphatase Gamma in Cancer;Frontiers in Cell and Developmental Biology;2022-01-05

5. Expression of FRS2 in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: an immunohistochemical analysis of 182 cases with genetic data;Diagnostic Pathology;2021-10-25